The leading CEO forum for pharmaceutical producers, distributors and retailers in Russia

12 - 13 May 2021

UNFORTUNATELY, DUE TO RESTRICTED CAPACITY THIS YEAR, OFFLINE PLACES FOR DAY ONE OF THE FORUM HAVE NOW SOLD OUT. 

However, you can still book to attend Day One online, and join the Cocktail Reception (Day One) and all of Day Two offline. Or you can book to attend the Forum in fully virtual format.

THE MOST IMPORTANT PHARMA EVENT IN RUSSIA IN 2021

The key event for the pharmaceutical industry, the 27th annual RUSSIAN PHARMACEUTICAL FORUM 2021 will take place on 12-13 May 2021 at our traditional venue, the Corinthia Hotel in SAINT PETERSBURG, as well as in  live ONLINE format. 
Join us at this meeting of the key international and Russian pharmaceutical industry experts! 

HYBRID FORMAT – MEET YOUR COLLEAGUES FACE-TO-FACE AND ONLINE


Meet new partners and network with the leading players on the pharmaceutical market – both in person in SAINT PETERSBURG (places strictly limited!), or via our online event platform, using live online chat, emails and video calls! 
If you are unable to join us in-person in St. Petersburg, you can connect to the event from your laptop, tablet or mobile phone – so you can save time travelling and maximise time learning from experts and engaging with speakers and other delegates. 

Speakers 2021

Elena Maksimkina, Head of Federal State Center For Planning And Organization Of Drug Supply , Ministry of Health of Russian Federation (Online)
Elena Maksimkina

Head of Federal State Center For Planning And Organization Of Drug Supply

Ministry of Health of Russian Federation (Online)

Dmitriy Galkin (ONLINE), acting Director of the Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of Russia
Dmitriy Galkin (ONLINE)

acting Director of the Department of Pharmaceutical and Medical Industry Development

Ministry of Industry and Trade of Russia

Dmitry Rozhdestvensky, Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation, Eurasian Economic Commission
Dmitry Rozhdestvensky

Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation

Eurasian Economic Commission

Vladislav Shestakov, Director, Federal State Institution
Vladislav Shestakov

Director

Federal State Institution "State Institute of Drugs and Good Practices" of the Ministry of Industry and Trade of the Russian Federation

Egor Zhavoronkov, Head of 'Pharma Group', CRPT
Egor Zhavoronkov

Head of 'Pharma Group'

CRPT

Dmitriy Travnikov, Head of Department for Provision of State Services , Federal Service for Intellectual Property (Rospatent)
Dmitriy Travnikov

Head of Department for Provision of State Services

Federal Service for Intellectual Property (Rospatent)

Elena Kartasheva, President, Takeda
Elena Kartasheva

President

Takeda

Katerina Pogodina, Managing Director, Russia & CIS, Johnson & Johnson
Katerina Pogodina

Managing Director, Russia & CIS

Johnson & Johnson

Stephan Eder, Executive Vice President, Russia and CIS, STADA
Stephan Eder

Executive Vice President, Russia and CIS

STADA

Oxana Monge, General Director, Eurasia, Sanofi
Oxana Monge

General Director, Eurasia

Sanofi

Vasily Ignatiev, General Director, R-Pharm
Vasily Ignatiev

General Director

R-Pharm

Matthias Wernicke, Managing Director, Russia and CIS, Merck
Matthias Wernicke

Managing Director, Russia and CIS

Merck

Peter Rodionov, General Manager, Geropharm
Peter Rodionov

General Manager

Geropharm

Vladimir Khristenko, President, Nanolek
Vladimir Khristenko

President

Nanolek

Vadim Tyrenko, Chief Cardiologist, Ministry of Defense of the Russian Federation
Vadim Tyrenko

Chief Cardiologist

Ministry of Defense of the Russian Federation

Dmitry Pogrebinsky, General Director, Protek
Dmitry Pogrebinsky

General Director

Protek

Elena Litvinova, General Director, NovaMedica
Elena Litvinova

General Director

NovaMedica

Alexander Kuzin, General Director, Pharmacy Chain 36.6
Alexander Kuzin

General Director

Pharmacy Chain 36.6

Alexander Semyonov, President, Active Component JSC
Alexander Semyonov

President

Active Component JSC

Yury Krestinskiy, Chairman of the Expert Board, Institute of Public Healthcare Development
Yury Krestinskiy

Chairman of the Expert Board

Institute of Public Healthcare Development

Oxana Kudelya, Market Access, Pricing and Commercial Director, Russia & CIS, Merck
Oxana Kudelya

Market Access, Pricing and Commercial Director, Russia & CIS

Merck

Maxim Stetsyuk, First Deputy General Manager, Nanolek
Maxim Stetsyuk

First Deputy General Manager

Nanolek

Rustam Iksanov, Vice President, R&D, NovaMedica
Rustam Iksanov

Vice President, R&D

NovaMedica

Vladimir Shipkov, Executive Director, AIPM Russia
Vladimir Shipkov

Executive Director

AIPM Russia

Viktor Dmitriev, General Director, Association of Russian Pharmaceutical Manufacturers
Viktor Dmitriev

General Director

Association of Russian Pharmaceutical Manufacturers

Alexei Shavenzov, GA&P Senior Director Russia & CIS, Johnson & Johnson
Alexei Shavenzov

GA&P Senior Director Russia & CIS

Johnson & Johnson

Alexander Rudko, General Director, R&D Centre NovaMedica Innotech
Alexander Rudko

General Director

R&D Centre NovaMedica Innotech

Vadim Kukava, Executive Director, Association of Pharmaceutical Companies “Innovative Pharma”
Vadim Kukava

Executive Director

Association of Pharmaceutical Companies “Innovative Pharma”

Evgeny Barinov, Deputy General Director, Chief Investment and Digital Officer, Nanolek
Evgeny Barinov

Deputy General Director, Chief Investment and Digital Officer

Nanolek

Marina Mazurevskaya, Deputy General Director, Legal Affairs & Governmental Relations, Nanolek
Marina Mazurevskaya

Deputy General Director, Legal Affairs & Governmental Relations

Nanolek

Vera Emelyanova, Medical Director, Ipsen
Vera Emelyanova

Medical Director

Ipsen

Anastasiya Chernousova, Head of Consumer Healthcare, Ipsen
Anastasiya Chernousova

Head of Consumer Healthcare

Ipsen

David Pérez Godia, Supply Chain Manager, Merck Biopharma Russia & CIS
David Pérez Godia

Supply Chain Manager

Merck Biopharma Russia & CIS

Olivier Simonnot, Senior Manager, Strategic Marketing Life Sciences EMEA, Sensitech
Olivier Simonnot

Senior Manager, Strategic Marketing Life Sciences EMEA

Sensitech

Nikita Ivanov, Senior Director, Corporate Affairs, Health & Value and Communications, Pfizer Russia & Belarus
Nikita Ivanov

Senior Director, Corporate Affairs, Health & Value and Communications

Pfizer Russia & Belarus

Alexey Migulin, Market Access Director, Pfizer Russia & Belarus
Alexey Migulin

Market Access Director

Pfizer Russia & Belarus

Nikolay Sonichev, Rare Disease BU Lead , Pfizer Russia & Belarus
Nikolay Sonichev

Rare Disease BU Lead

Pfizer Russia & Belarus

Mariya Burchakova, Market Access and Public Affairs Director, Russia & CIS, Ipsen
Mariya Burchakova

Market Access and Public Affairs Director, Russia & CIS

Ipsen

Igor Bakhmetiev, Commercial Director, Russia and CIS, STADA
Igor Bakhmetiev

Commercial Director, Russia and CIS

STADA

Stanislav Naumov, General Manager, Eurasian Centre for Integrational Research and Communication
Stanislav Naumov

General Manager

Eurasian Centre for Integrational Research and Communication

Ekaterina Creanga, General Manager, LifeScan
Ekaterina Creanga

General Manager

LifeScan

Evgeny Korotkov, General Director, Proapteka
Evgeny Korotkov

General Director

Proapteka

Boris Popov (ONLINE), Commercial Director, CV Protek
Boris Popov (ONLINE)

Commercial Director

CV Protek

Nelly Ignatieva, Executive Director, Russian Association of Pharmacy Chains
Nelly Ignatieva

Executive Director

Russian Association of Pharmacy Chains

Viktoria Presnyakova, Director, Association of Indepedent Pharmacies
Viktoria Presnyakova

Director

Association of Indepedent Pharmacies

Alexey Konov, Founder, Managing Partner            , RBV Capital
Alexey Konov

Founder, Managing Partner

RBV Capital

Alexander Shishkin, General Director, Group of Companies ASNA
Alexander Shishkin

General Director

Group of Companies ASNA

Natalya Petlyuk, Eyecare Department Managing Director, Alcon Russia
Natalya Petlyuk

Eyecare Department Managing Director

Alcon Russia

Alexander Kotlyarov, Project Manager, vseapteki.ru , Mail.Ru Group
Alexander Kotlyarov

Project Manager, vseapteki.ru

Mail.Ru Group

Vladimir Nesterenko, Managing Director, GDP
Vladimir Nesterenko

Managing Director

GDP

Mikhail Khazanchuk, Quality & Compliance Senior Manager, Russia, Ukraine, Central & Eastern Europe, Johnson & Johnson
Mikhail Khazanchuk

Quality & Compliance Senior Manager, Russia, Ukraine, Central & Eastern Europe

Johnson & Johnson

Vitaly Dembrovskiy, Market Access Director, Russia and Eurasia, AstraZeneca
Vitaly Dembrovskiy

Market Access Director, Russia and Eurasia

AstraZeneca

Natalia Polushkina, Vice President, Biomedical Cluster, Skolkovo
Natalia Polushkina

Vice President, Biomedical Cluster

Skolkovo

Alexander Filippov, General Director, Rigla (Online)
Alexander Filippov

General Director

Rigla (Online)

Elena Popova, Senior Director Regulatory Affairs & Healthcare Policy, AIPM Russia
Elena Popova

Senior Director Regulatory Affairs & Healthcare Policy

AIPM Russia

Nikolay Lyskov, Head of the Department of Chemistry, Biotechnology and Medicine, Federal Institute of Industrial Property
Nikolay Lyskov

Head of the Department of Chemistry, Biotechnology and Medicine

Federal Institute of Industrial Property

Alexandr Sokolov, Key Account Director, Teva
Alexandr Sokolov

Key Account Director

Teva

Andrey Kolesnikov, Director Government Affairs & Market Access, Russia and Eurasia , Teva
Andrey Kolesnikov

Director Government Affairs & Market Access, Russia and Eurasia

Teva

Margarita Mustafina, Quality Director, Russia and Eurasia, Teva
Margarita Mustafina

Quality Director, Russia and Eurasia

Teva

Dmitry Koloda, Executive Director of Medical Affairs  , Takeda Russia
Dmitry Koloda

Executive Director of Medical Affairs

Takeda Russia

Irina Ivanishcheva (ONLINE), Corporate Affairs and Legal Director, AstraZeneca Russia & Eurasia
Irina Ivanishcheva (ONLINE)

Corporate Affairs and Legal Director

AstraZeneca Russia & Eurasia

Irina Skityayeva, HR Director, STADA Russia and CIS
Irina Skityayeva

HR Director

STADA Russia and CIS

Valeria Balashova, HR Director of R&D Center, Novamedica Innotech
Valeria Balashova

HR Director of R&D Center

Novamedica Innotech

Vasiliy Saveliev, Digitalisation Director Russia and Eurasia, Teva
Vasiliy Saveliev

Digitalisation Director Russia and Eurasia

Teva

Alexey Fedorov, Independent Expert,
Alexey Fedorov

Independent Expert

Kirill Danishevskiy, Market Access Director, Takeda
Kirill Danishevskiy

Market Access Director

Takeda

Alexander Martinenko, Industrial Policy Director, AIPM
Alexander Martinenko

Industrial Policy Director

AIPM

Maxim Agarev, Director of GR projects, Yandex.market
Maxim Agarev

Director of GR projects

Yandex.market

Sergey Demin, Commercial Director, Pharmacy Chain 36.6
Sergey Demin

Commercial Director

Pharmacy Chain 36.6

Vilena Galkina, Government Affairs Director, Geropharm
Vilena Galkina

Government Affairs Director

Geropharm

Andrey Telyatnikov, Deputy General Commercial Manager , GDP
Andrey Telyatnikov

Deputy General Commercial Manager

GDP

Alexandra Arendar, HR Director, Geropharm
Alexandra Arendar

HR Director

Geropharm

Marina Rykova, Strategic Marketing Director, Geropharm
Marina Rykova

Strategic Marketing Director

Geropharm

Arminas Macevicius, Regional Director , Stada CIS (Online)
Arminas Macevicius

Regional Director

Stada CIS (Online)

Anastasia Kruglova, Country Principal, Russia & CIS, IQVIA
Anastasia Kruglova

Country Principal, Russia & CIS

IQVIA

Maria Denisova, Associate Operations / Resources Director, IQVIA
Maria Denisova

Associate Operations / Resources Director

IQVIA

Alexander Saverskiy, President, All-Russian Public Organisation 'Patient Protection League'
Alexander Saverskiy

President

All-Russian Public Organisation 'Patient Protection League'

Alexander Bykov, Director of Healthcare Economics, R-Pharm
Alexander Bykov

Director of Healthcare Economics

R-Pharm

Andrey Odabashian, Head of Legal Services to Pharmaceutical Companies, PwC Legal
Andrey Odabashian

Head of Legal Services to Pharmaceutical Companies

PwC Legal

Anna Ruvinskaya, Director, Pharmaceutical and Medico-Biological Companies Services Practice, PwC
Anna Ruvinskaya

Director, Pharmaceutical and Medico-Biological Companies Services Practice

PwC

Sergey Shulyak, General Director, DSM Group
Sergey Shulyak

General Director

DSM Group

Herman Inozemtsev, Government and External Relations Director, Santens Group of Companies
Herman Inozemtsev

Government and External Relations Director

Santens Group of Companies

Evgeniy Gordeev, Managing Partner, Breffi
Evgeniy Gordeev

Managing Partner

Breffi

Igor Perevozchikov, CEO, ADV Lab & Benchmark
Igor Perevozchikov

CEO

ADV Lab & Benchmark

Yan Vlasov, Co-Chair, Russian Patients Association
Yan Vlasov

Co-Chair

Russian Patients Association

Ilya Naroditskii, Technology Principal, IQVIA
Ilya Naroditskii

Technology Principal

IQVIA

Evgeniy Smirnov, Commercial Director, Navicon
Evgeniy Smirnov

Commercial Director

Navicon

Konstantin Perov, Director, Institute of Competitive Technologies
Konstantin Perov

Director

Institute of Competitive Technologies

Frederic Jumel, General Manager, Sanofi Pasteur
Frederic Jumel

General Manager

Sanofi Pasteur

Nuriya Musina (ONLINE), Head of Development and External Affairs Department, The Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation (Online)
Nuriya Musina (ONLINE)

Head of Development and External Affairs Department

The Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation (Online)

Sergey Eskin, Director , Pulse Pharmaceutical Company
Sergey Eskin

Director

Pulse Pharmaceutical Company

Alexander Mazurov, Chief Digital Officer, Russia and Eurasia, Sanofi
Alexander Mazurov

Chief Digital Officer, Russia and Eurasia

Sanofi

Vladimir Egorov, General Manager, Proxima Research Russia
Vladimir Egorov

General Manager

Proxima Research Russia

Polina Zvezdina, Chief Editor, Pharmvestnik
Polina Zvezdina

Chief Editor

Pharmvestnik

Marina Shepotinenko, Multi-channel and Trade Marketing  Director, Proxima Research in Russia
Marina Shepotinenko

Multi-channel and Trade Marketing Director

Proxima Research in Russia

Marina Shipulina, Co-President, Russian Diabetic Federation
Marina Shipulina

Co-President

Russian Diabetic Federation

Oleg Feldman, Managing Director, Ipsos Healthcare (Online)
Oleg Feldman

Managing Director

Ipsos Healthcare (Online)

Anton Prozumentov, Head, Specialized Medicines Division , Nanolek
Anton Prozumentov

Head, Specialized Medicines Division

Nanolek

Dmitriy Kudlay (ONLINE), VP Innovation, Generium
Dmitriy Kudlay (ONLINE)

VP Innovation

Generium

Natalya Parshikova (ONLINE), Marketing Director, SBER EAPTEKA
Natalya Parshikova (ONLINE)

Marketing Director

SBER EAPTEKA

Svetlana Karimova, President, National Association of Rare Disease Organisations 'Genetica'
Svetlana Karimova

President

National Association of Rare Disease Organisations 'Genetica'

Anton Gopka, Co-Founder and General Partner, ATEM Capital
Anton Gopka

Co-Founder and General Partner

ATEM Capital

Lilia Titova, Executive Director, The Union of Professional Pharmaceutical Organizations (SPFO)
Lilia Titova

Executive Director

The Union of Professional Pharmaceutical Organizations (SPFO)

Veronika Galyamova, Executive Director, Katren
Veronika Galyamova

Executive Director

Katren

Almira Galeeva, Director of Clinical Research & Medical Affairs, AIPM Russia
Almira Galeeva

Director of Clinical Research & Medical Affairs

AIPM Russia

Anatoliy Tentser,  Director  of Development , Katren
Anatoliy Tentser

Director of Development

Katren

Irina Sheykkha, Legal and IP Director, AIPM Russia
Irina Sheykkha

Legal and IP Director

AIPM Russia

Elena Zaikina, Business Ethics Director, Takeda
Elena Zaikina

Business Ethics Director

Takeda

Batyrkhan Kuatov, Market Access Head Russia and CIS, CSL Behring
Batyrkhan Kuatov

Market Access Head Russia and CIS

CSL Behring

Sergey Avdeenko, Head of PR and Government Affairs, Roche
Sergey Avdeenko

Head of PR and Government Affairs

Roche

Alexandr Sumin, Responsible Secretary, Expert Committee on Drug Regulation, Pharmaceutical and Medical Industry Development , Russian State Duma Healthcare Committee
Alexandr Sumin

Responsible Secretary, Expert Committee on Drug Regulation, Pharmaceutical and Medical Industry Development

Russian State Duma Healthcare Committee

Pavel Sagitov, Head of Disctribution and Tender Channel, GSK Pharma
Pavel Sagitov

Head of Disctribution and Tender Channel

GSK Pharma

Olga Molina (ONLINE), HR Director, Sandoz Russia
Olga Molina (ONLINE)

HR Director

Sandoz Russia

Anna Ermolaeva, General Director, AlphaRM
Anna Ermolaeva

General Director

AlphaRM

Vadim Tarasov (Online), Director, Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University of the Russian Ministry of Health
Vadim Tarasov (Online)

Director

Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University of the Russian Ministry of Health

Elena Khvostikova, Director, “Genome” Patient Support Centre
Elena Khvostikova

Director

“Genome” Patient Support Centre

Elena Bachinskaya, Medical Director, Sandoz (Online)
Elena Bachinskaya

Medical Director

Sandoz (Online)

Maria Prikhodko, Legal and Compliance Specialist, AIPM
Maria Prikhodko

Legal and Compliance Specialist

AIPM

Andrey Sarana, First Deputy Chairman, Health Committee of St. Petersburg
Andrey Sarana

First Deputy Chairman

Health Committee of St. Petersburg

Natalia Bessonova, Head of Rare Diseases and Multiple Sclerosis Units, Sanofi*
Natalia Bessonova

Head of Rare Diseases and Multiple Sclerosis Units

Sanofi*

Irina Borovova, President, Association of Oncology Patients “Zdravstvuy!”
Irina Borovova

President

Association of Oncology Patients “Zdravstvuy!”

Konstantin Isanin, Head of Trade Marketing, Yandex.Market
Konstantin Isanin

Head of Trade Marketing

Yandex.Market

Ilya Keltsev, E-Commerce Lead, Bayer
Ilya Keltsev

E-Commerce Lead

Bayer

Oxana Krasnykh, Vice President for Marketing and Commerce, Petrovax
Oxana Krasnykh

Vice President for Marketing and Commerce

Petrovax

Oxana Baranova, Deputy Chief Editor, Pharmvestnik
Oxana Baranova

Deputy Chief Editor

Pharmvestnik

Yuri Lobzin, Director, Children's Research and Clinical Center for Infectious Diseases (of the Federal Medical and Biological Agency)
Yuri Lobzin

Director

Children's Research and Clinical Center for Infectious Diseases (of the Federal Medical and Biological Agency)

Natalya Maskina, Reviewer
Natalya Maskina

Reviewer "Career & HR"

Pharmvestnik

Alexander Petrovsky, Deputy Director for Educational Activities, N. N. Blokhin Russian Cancer Research Center
Alexander Petrovsky

Deputy Director for Educational Activities

N. N. Blokhin Russian Cancer Research Center

Pavel Shabalkin, Oncologist, Association of Oncology Patients
Pavel Shabalkin

Oncologist

Association of Oncology Patients "Zdravstvuy!"

Anastasia Tatarnikova, Chairman of the Board,
Anastasia Tatarnikova

Chairman of the Board

"House of Patients with Orphan Diseases" (Online)

Natalia Vezikova, MD, Professor, Chair of Therapy Faculty, Chief Freelance Specialist Therapist, Karelia Republic
Natalia Vezikova

MD, Professor, Chair of Therapy Faculty, Chief Freelance Specialist Therapist

Karelia Republic

Marina Zhuravleva, Chief Freelance Specialist Clinical Pharmacologist, Moscow Department of Health
Marina Zhuravleva

Chief Freelance Specialist Clinical Pharmacologist

Moscow Department of Health

Interview with Alexey Savin – Regional Principal, Eastern Europe, Russia & CIS – IQVIA 

Key topics at the Russian Pharmaceutical Forum 2021:

The Russian Pharma Forum is an annual meeting place, the main platform for active and productive dialogue between all the principal stakeholders in the Russian pharmaceutical market. What questions will be discussed in 2021? 
 
 
REGULATION OF THE SECTOR

  • How has the pandemic affected the pharma regulatory landscape?
  • Upcoming regulatory changes: what is important to know? 
     
     
    PRODUCTION
  • Establishing new strategic partnerships with the leading international producers
  • Production localisation and technology transfer of breakthrough drugs
  • Development of active pharmaceutical substance production in Russia 
     
     
    DISTRIBUTION
  • Evolution of the wholesale segment and pharmaceutical logistics
  • Examples of new technologies in product distribution management
  • Vertical integration – a new model of development for distribution businesses 
     
     
    RETAIL
  • Development of the distance retail model for pharmaceutical products in Russia
  • Challenges of implementing new methods of medical product delivery
  • New kinds of competition and cooperation: pharma aggregators and marketplaces 
     
     
    TECHNOLOGY
  • Integration of advanced production and research technologies and processes
  • How to ensure consistent international quality standards  in drug manufacturing
  • Big data in the pharmaceutical industry: from RWE to sales. Myths and reality 
     
     
    INNOVATION
  • Development and market launch of new highly effective therapies in Russia
  • Local research and development and products for treating complex diseases
  • Lessons of COVID-19: breakthroughs in immunology, investment into vaccine development  
     
     
    PATIENTS
  • How to make modern medical treatments highly accessible to patients?
  • Paradigm shift – what is a socially responsible pharmaceutical business?
  • What are the obstacles to successfully implementing a patient-oriented approach to healthcare? 
     
     
    HEALTHCARE
  • Integrated solutions for the digital transformation of the healthcare system 
  • Pharmaceutical industry and primary healthcare modernisation programme in Russia
  • The role of pharmaceutical companies in expanding access to quality healthcare 
     
     
    SALES AND PROMOTION
  • How to still survive and thrive when customer buying- power is reduced?
  • What does an effective marketing strategy look like in the post-Covid era l?
  • Market-leading case studies of digital visits by medical representatives 
     
    ANALYTICS
  • Overview of the current state of the market and forecasts for future developments in Russia
  • Which strategic directions should you prioritise and invest in today? 
    Competition on the Russian pharmaceutical market – leaders and new players 

Pharma versus coronavirus: interviews with General Directors 

General Directors of the leading companies on the market have discussed with the Russian Pharmaceutical Forum the main challenges they are facing during the pandemic, and possible approaches to collaborating with the government on developing both a vaccine and treatments for COVID-19. 

The SARS-CoV-2 coronavirus pandemic has kicked the rate of development in the pharmaceutical industry into a new gear. At the early stages of the epidemic in Russia, the demand for medical masks, antiseptics and antivirals soared. A series of regulatory decisions followed, taken at an unprecedented speed, outlining a new set of rules for maximum retail prices and distance selling of medical products. 

The pharmaceutical industry is undergoing enormous change fuelled by a global crisis in healthcare. But pharma also has a key role to play in the search for ways out of the current situation. 

 

READ OUR PHRAMACEUTICAL BLOG>>

The most important pharmaceutical conference in Russia! Excellent opportunity to meet your key partners in one place

ALES SUSSINGER,

Commercial Director, KRKA FARMA

RUSSIAN PHARMACEUTICAL FORUM ATTENDEES INCLUDE:

Abbott Laboratories
AbbVie
Alfa Wassermann
Allergan
Almirall
Amgen
Angelini Francesco
Baxter
Bayer Pharma
Belupo
Berlin-Chemie
Besins Healthcare

Biogen Interntional
Bittner Pharma
Boehringer Ingelheim
Boiron
Bosnalijek
Bristol-Myers Squibb
EGIS
Eisai
Eli Lilly Vostok
Galderma
Glenmark Pharmaceuticals
Hikma Pharmaceuticals

Ipsen
KRKA Pharma
Lupin
Merck
Nanolek
Novo Nordisk
Petrovax Pharm
Ranbaxy
Reckitt Benckiser
Roche
Servier
Shreya Life Sciences

WHY TO ATTEND THE RUSSIAN PHARMACEUTICAL FORUM?

russianpharma 023

27 years in the market! Russia's longest-running pharmaceutical forum

russianpharma 018

The highest profile executive-level speakers and attendees

russianpharma 150

Unrivalled networking opportunities - meet key decision makers